Home > > > > Report Detail

Investigation Report on China Lamivudine Market, 2010-2019

Publisher Name :
Date: 02-Jul-2015
No. of pages: 35

Acoording to the report issued by the Joint United Nations Programme on HIV and AIDS in 2014, by the end of 2013, patients with human immune deficiency virus/acquired immune deficiency syndrome (HIV/ AIDS) had amounted to 35 million and the number of new cases of HIV/AIDS had been 6000 a day on average. And by the end of 2011, patients with HIV/ AIDS in China was estimated to be 0.78 million, the number of new cases of HIV/AIDS was 48,000 and people die of diseases related with AIDS reached 28,000.

Lamivudine, an important drug for hepatitis B Virus (HBV) and AIDS, is one of the products regulated by the Chinese government to be provided to patients with AIDS (patients with hepatitis B not included) for free. As an antiviral nucleotide analog, lamivudine can competitively inhibit the synthesis and elongation of viral DNA chain. First used by some countries in Europe and North America for the treatment of AIDS in the early 1990s, lamivudine was approved by FDA to be used for the treatment of hepatitis B in 1998 after some medical experts discovered its inhibiting effect on HBV DNA in the middle 1990s. Lamivudine was approved by CFDA mainly as hepatitis B drug and began its sales in China in 1999.

Lamivudine develops fast after entering China with sales value reaching up to CNY 307 million in 2012 despite its gradual drop since 2013. GlaxoSmithKline Pharmaceuticals (Suzhou) Limited, Beijing Wansheng Pharmaceutical Co., Ltd, Burroughs Wellcome & Company (UK) and Fujian Cosunter Pharmaceutical Co., Ltd occupy the majority of the Chinese market, among which GlaxoSmithKline Pharmaceuticals (Suzhou) Limited had the largest market share of about 72% for sales value in 2014.
With the large amounts of patients with hepatitis B and AIDS in China, the market size of lamivudine is expected to have growth potential.

Readers can get at least the following information from this report:


  • market size of lamivudine in China

  • competitive landscape of lamivudine in Chinese market

  • price of lamivudine made by different enterprises in China

  • market outlook of lamivudine in China


The author suggests the following groups of people purchase this report:


  • manufacturers of antiHBV drugs

  • manufacturers of antiAIDS drugs

  • investors/ research institutions interested in Chinese medicine market

  • any interest in the Chinese medicine market, please contact CRI for customized survey service

Investigation Report on China Lamivudine Market, 2010-2019

Table of Contents

1 Related Concepts of Lamivudine
1.1 Indication
1.2 Sales Status in Global Market

2 Market Profile of Lamivudine in China
2.1 Patent and Approval Status of Lamivudine in China
2.2 Major Manufacturers
2.3 Market Size

3 Survey on Sales Status of Lamivudine in China, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions

4 Survey on Market Share of Major Manufacturers of Lamivudine in China, 2010-2014
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume

5 Survey on Dosage Forms of Lamivudine in China, 2010-2014
5.1 Share of Different Dosage Forms by Sales Value
5.2 Share of Different Dosage Forms by Sales Volume

6 Reference Price of Lamivudine in Chinese Hospitals in 2014
6.1 Beijing Wansheng Pharmaceutical Co., Ltd (Trade Name: Wanshenglike)
6.2 Burroughs Wellcome & Company (UK) (Trade Name: Heptodin)
6.3 Anhui Biochem United Pharmaceutical Co., Ltd (Trade Name: Yinding)
6.4 Hunan Qianjin Xiangjiang Pharmaceutical Industry Co., Ltd (Trade Name: Jianganling)
6.5 Fujian Cosunter Pharmaceutical Co., Ltd (Trade Name: Heganding)
6.6 GlaxoSmithKline Pharmaceuticals (Suzhou) Limited (Trade Name: Heptodin)

7 Major Manufacturers of Lamivudine in Chinese Market, 2010-2014
7.1 Anhui Biochem United Pharmaceutical Co., Ltd
7.2 Fujian Cosunter Pharmaceutical Co., Ltd
7.3 Beijing Wansheng Pharmaceutical Co., Ltd
7.4 GlaxoSmithKline Pharmaceuticals (Suzhou) Limited
7.5 Hunan Qianjin Xiangjiang Pharmaceutical Industry Co., Ltd

8 Market Outlook of Lamivudine in China, 2015-2019
8.1 Forecast of Market Size
8.2 Forecast of Competitive Landscape

List of Charts

Chart Patent Status of Lamivudine in China
Chart Approval Information of Lamivudine in China
Chart Sales Status of Lamivudine in China
Chart Sales Value of Lamivudine in China, 2010-2014
Chart Sales Value of Lamivudine in Some Regions in China, 2010-2014
Chart Sales Volume of Lamivudine in China, 2010-2014
Chart Market Share of TOP3 Manufacturers of Lamivudine for Sales Value in China, 2010-2014
Chart Sales Value and Market Share of Lamivudine Made by GlaxoSmithKline Pharmaceuticals (Suzhou) Limited in China, 2010-2014
Chart Sales Value and Market Share of Lamivudine Made by Burroughs Wellcome & Company (UK) in China, 2010-2014
Chart Sales Value and Market Share of Lamivudine Made by Fujian Cosunter in China, 2010-2014
Chart Sales Value and Market Share of Lamivudine Tablets in China, 2010-2014
Chart Sales Value and Market Share of Lamivudine Capsules in China, 2010-2014
Chart Sales Volume and Market Share of Lamivudine Tablets in China, 2010-2014
Chart Sales Volume and Market Share of Lamivudine Capsules in China, 2010-2014
Chart Price of Lamivudine Made by Beijing Wansheng Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Lamivudine Made by Burroughs Wellcome & Company (UK) in Some Chinese Cities in 2014
Chart Price of Lamivudine Made by Anhui Biochem United Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Lamivudine Made by Hunan Qianjin Xiangjiang Pharmaceutical Industry Co., Ltd in Some Chinese Cities in 2014
Chart Price of Lamivudine Made by Fujian Cosunter Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Lamivudine Made by GlaxoSmithKline Pharmaceuticals (Suzhou) Limited in Some Chinese Cities in 2014

  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
    • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs